Related Experiment Video
Updated: Jan 10, 2026
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
[COVID-19 and non-COVID-19 pneumonia, a comparative study]
Melani Zlotogora1, Santiago T M Reyna1, María A Correa Barovero1
1Servicio de Clínica Médica, Hospital Privado Universitario de Córdoba, Argentina.
Introduction:
The clinical management of pneumonia in hospitalized patients remains a constant medical challenge, particularly during the SARS-CoV-2 pandemic, due to its heterogeneous presentation and the need for timely diagnostic and therapeutic decisions. The objective of this study was to describe the frequency and clinical characteristics of community-acquired pneumonia (CAP) and COVID-19 pneumonia in hospitalized patients, and to evaluate the performance of various prognostic scores.
Materials And Methods:
This was a retrospective analytical study conducted at two tertiary care hospitals in Córdoba, Argentina. Patients aged over 18 years with a diagnosis of CAP or COVID-19 pneumonia who were hospitalized between March 2020 and October 2021 were included. Pregnant women were excluded.
Results:
A total of 1176 patients with COVID-19 pneumonia and 124 with CAP were included. COVID-19 pneumonia occurred more frequently in males (748 [63.6%] vs. 66 [53.2%]; p=0.02) and in younger patients (median age= 60; IQR= 49-71 vs. median=70.5; IQR= 52-80; p<0.001). Severe forms were more frequent in COVID-19 cases (723 [61.5%] vs. 61 [49.2%]; p=0.003), as was progression from mild to severe illness (103/529, 19.5% vs. 3/75, 4%; p<0.001). At admission, CURB-65 and qSOFA scores identified most cases as low risk; however, the 4C mortality and CALL scores showed better performance in predicting complications. In-hospital mortality was similar between groups (143/1176, 12.2% vs. 14/124, 11.3%; p=0.78).
Discussion:
Hospitalized pneumonia cases, whether COVID-related or not, predominantly affected patients with comorbidities. Prognostic stratification using the 4C mortality and CALL scores demonstrated better predictive performance for unfavorable outcomes.
More Related Videos
03:53Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
01:29Pneumonia II: Pathophysiology
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....